Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer
Era of hope for patients with lung cancer
21 November 2022Internal medicine physicians call for improved access and quality in health care for incarcerated patients
21 November 2022Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer
Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART. Approximately 25% of the study’s participants were patients treated at the Henry Ford Pancreatic Cancer Center (HFPCC).
